Javier Arias-Stella

Dr. Javier Arias-Stella

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in Urologic Oncology: Seminars and Original Investigations
Verified
Journal Article
Closed access
GCGerardo Cabanillas
Gerardo Cabanillas
DMDiego Montoya-Cerrillo
Diego Montoya-Cerrillo
OKOleksandr N. Kryvenko
Oleksandr N. Kryvenko
SPSumanta K. Pal
Sumanta K. Pal
JAJavier Arias-Stella
Javier Arias-Stella

1 June 2019 in Human Pathology
Verified
Journal Article
Closed access
SGSounak Gupta
Sounak Gupta
CVChad M. Vanderbilt
Chad M. Vanderbilt
PCPaolo Cotzia
Paolo Cotzia
JAJavier Arias-Stella
Javier Arias-Stella
JCJason C. Chang
Jason C. Chang
DRDara S. Ross
Dara S. Ross

1 March 2019 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
SGSounak Gupta
Sounak Gupta
CVChad M. Vanderbilt
Chad M. Vanderbilt
PCPaolo Cotzia
Paolo Cotzia
JAJavier Arias-Stella
Javier Arias-Stella
JCJason C. Chang
Jason C. Chang
DRDara S. Ross
Dara S. Ross

1 July 1994 in American Journal of Surgical Pathology
Verified
Journal Article
Closed access
JAJavier Arias-Stella
Javier Arias-Stella
AAA Arias-Velasquez
A Arias-Velasquez
The presence of mitotic figures was investigated in 215 cases of florid atypical endometrial change associated with chorionic tissue effect. Mitoses were found in 13.4% of the cases. Mitoses were occasionally observed in 10.2% of cases, and they were multiple in single microscopic fields in 2.7%. Abnormal mitoses were noted in 3.2% of the cases. The occurrence of normal and abnormal mitoses was mainly related to the early secretory type of abnormality. These observations have biologic implications, but of more practical interest, they indicate that the presence of mitoses per se are an insufficient criteria for the diagnosis of clear-cell carcinoma, particularly in women during their reproductive period.

1 July 2016 in Journal of Investigative Medicine High Impact Case Reports
Verified
Journal Article
Open access
MMMelissa Matzumura
Melissa Matzumura
JAJavier Arias-Stella
Javier Arias-Stella
JNJames E. Novak
James E. Novak
Erdheim-Chester disease (ECD) is a rare, xanthogranulomatous, non-Langerhans cell histiocytosis with frequent systemic involvement. Although the diagnosis is based on characteristic histological and radiological findings, its identification can be challenging because of its heterogeneous presentation. Osteosclerosis of long bones, often associated with bone pain, is the most common initial manifestation, followed by extraskeletal manifestations in approximately 50% of cases. There is no standard treatment for ECD, although recommendations have been made on the basis of small studies. A systematic approach to the diagnosis of ECD is important, because its manifestations may be life-threatening and may require specific management. We report an atypical presentation of ECD, with early cardiac, renal, and central nervous system involvement, and only late skeletal manifestations.

14 April 2023 in Genes, Chromosomes and Cancer
Verified
Journal Article
Open access
HCHugo Carrillo-Ng
Hugo Carrillo-Ng
YLYu Liang
Yu Liang
SCSue Chang
Sue Chang
MAMichelle Afkhami
Michelle Afkhami
TGThomas Gernon
Thomas Gernon
JAJavier Arias-Stella
Javier Arias-Stella
Rhabdomyosarcomas (RMS) are malignant mesenchymal tumors with skeletal muscle differentiation which are classified into alveolar, embryonal, pleomorphic, and spindle cell/sclerosing RMS. Within the spindle cell/sclerosing RMS tumor type there is a recently recognized sub-type categorized as intraosseous spindle cell RMS with TFCP2/NCOA2 gene fusion. This rare tumor is highly aggressive with predominant involvement of the craniofacial and pelvic bones with approximately 30 cases reported to date. Histopathologic features include spindle cell and epithelioid morphology with a characteristic co-expression of epithelial markers, myogenic markers, and ALK1 expression. We report two cases of gnathic spindle cell/sclerosing RMS with FUS::TFCP2 gene fusion that were initially interpreted as carcinomas by referring institutions and later reclassified when encountered in our practice after additional work-up and molecular characterization.